# TissueTinker

> TissueTinker builds a benchtop 3D bioprinting system that produces physiologically relevant human tumor models on demand, letting preclinical oncology teams run cancer models in-house in weeks rather than outsourcing to CROs or animal studies.

TissueTinker is a Montréal-based preclinical oncology company. Its system pairs a low-cost bioprinter, a digital library of ready-to-print tissue models, and tissue-specific bioinks made from organ-derived decellularized extracellular matrix (dECM) that match the mechanical and biochemical properties of real tumor tissue. The models are compatible with standard well plates, assays, and imaging, and with other new approach methodologies (NAMs) such as organoids and organ-on-a-chip.

## Core pages

- [The System](https://tissuetinker.com/system/): how the bioprinter, model library, and TTB-Series bioinks work, and how the models compare to 2D culture, spheroids, and generic scaffolds.
- [Resources](https://tissuetinker.com/resources/): the free technical whitepaper and selected literature.
- [Early Access](https://tissuetinker.com/early-access/): how to become a founding early access partner.
- [Team](https://tissuetinker.com/team/): the people and supporters behind TissueTinker.

## Optional

- [News](https://tissuetinker.com/news/): company updates and press coverage.
- [Privacy Policy](https://tissuetinker.com/privacy/): how personal data is handled.